Am J Transplant, Volume 22, Suppl 3 Archives - Page 178 of 190 - ATC Abstracts

2022 American Transplant Congress
Liver Transplant Recipient History of Criminality: Impact on Clinical Outcomes
M. M. French¹, R. Mangus¹, R. Holmes¹, A. Krause¹, J. Sumner¹, C. Kubal¹, B. Ekser², P. Mihaylov³, A. Lutz⁴, J. Fridell⁵
¹Department of Surgery, Indiana University, Indianapolis, IN, ²Surgery, Indiana University - Transplant Surgery, Indianapolis, IN, ³Department of Surgery, Indiana Univ School of Medicine, Indianapolis, IN, ⁴Department of Surgery, Indiana University, Fishers, IN, ⁵Department of Surgery, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Health disparities are present in transplantation, just as in other areas of medicine. This is a retrospective review of liver transplant (LT) recipients to…
2022 American Transplant Congress
Direct Procurement of Heart and Lungs from a Controlled DCD Donor with Ongoing Abdominal Normothermic Regional Perfusion (aNRP) – A Synchronized Retrieval
M. Husain¹, A. Jothidasan¹, C. Zeschky¹, M. Osman², M. Berman², R. Gaurav³, A. Butler³, C. Watson³, B. Stutchfield⁴, I. Currie⁵, G. Oniscu⁵, J. Dunning¹, U. Stock¹
¹Department of Cardiothoracic Surgery, Transplantation and MCS, Royal Brompton & Harefield Hospitals Part of Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom, ²Department of Heart and Lung Transplant, Royal Papworth Hospital, Cambridge, United Kingdom, ³Roy Calne Transplant Unit, Department of Surgery, Addenbrookes Hospital, Cambridge University NHS Trust, Cambridge, United Kingdom, ⁴Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, Edinburgh, United Kingdom, ⁵Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
*Purpose: With the increased number of aNRP in controlled DCD donors comes a high demand for techniques to directly procure cardiothoracic organs during the aNRP.…
2022 American Transplant Congress
Mhealth Coaching Improves Patient Activation and Nutritional Behaviors in Diverse Renal Transplant Recipients
M. Pollack¹, N. Stauffer², H. Lee², I. Satoru², M. Ellis³, C. Diamantidis³, S. Docherty⁴, E. T. Chambers⁵
¹Psychiatry, Duke University, Durham, NC, ²Biostatistics, Duke University, Durham, NC, ³Internal Medicine, Duke University, Durham, NC, ⁴School of Nursing, Duke University, Durham, NC, ⁵Pediatrics, Duke University, Durham, NC
*Purpose: Kidney transplant recipients who are not actively engaged in their care and lack self-management skills have poor transplant outcomes. These suboptimal outcomes are disproportionately…
2022 American Transplant Congress
Interleukin-31 (IL-31) and Leukemia Inhibitory Factor (LIF) Are Upregulated in Acute Rejection of Kidney Allograft
I. Striz, L. Krupickova, M. Fialova, M. Novotny, E. Cecrdlova, O. Viklicky
Institute for Clinical and Experimental Medicine, Praha, Czech Republic
*Purpose: Interleukin-31 (IL-31) and leukemia inhibitory factor (LIF) belong to the IL-6 cytokine family clustered by their pro-inflammatory properties and a shared signaling pathway of…
2022 American Transplant Congress
Understanding the Impact of Financial Obstacles and Reimbursement for Lost Wages on the Decision-Making Process for Living Organ Donation
R. J. Mandell¹, A. R. Smith¹, K. A. Gifford², B. A. Hong³, N. P. Goodrich¹, A. K. Mathur⁴, M. A. Fava¹, A. O. Ojo⁵, R. M. Merion¹
¹Arbor Research Collaborative for Health, Ann Arbor, MI, ²American Society of Transplant Surgeons, Arlington, VA, ³Washington University in St. Louis, St. Louis, MO, ⁴Mayo Clinic in Arizona, Phoenix, AZ, ⁵University of Kansas Medical Center, Kansas City, KS
*Purpose: This study examined the impact of financial obstacles (e.g., lost wages, travel, and dependent care expenses) on the decision to initiate an evaluation for…
2022 American Transplant Congress
Utility of Donor Derived Cell-Free DNA in Liver Transplantation
A. Zarrinpar, D. Lewis, C. Warren, S. Duarte
Surgery, University of Florida, Gainesville, FL
*Purpose: As a non-invasive measure of allograft injury, quantifying the fraction of donor-derived cell-free DNA (dd-cfDNA) has proven to be useful technique in kidney transplantation.…
2022 American Transplant Congress
Early Experience with 4-drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients
S. Mouawad¹, C. Shoemaker², J. Geyston³, A. Nishio Lucar³
¹University of Virginia Health System, Charlottesville, VA, ²Pharmacy, UVA Health, Charlottesville, VA, ³University of Virginia, Charlottesville, VA
*Purpose: Belatacept based immunosuppression regimens in kidney transplant recipients have been associated with better kidney function, improved metabolic profile, less de novo DSA formation and…
2022 American Transplant Congress
Kidney Transplant Related Knowledge Among African, Caribbean and Black Canadian Patients with Kidney Failure
M. Hamid¹, H. Habbal¹, A. Wasim¹, E. Rogers¹, M. Anwar¹, R. Li¹, S. Macanovic¹, A. D. Waterman², I. Mucsi¹
¹University Health Network, Toronto, ON, Canada, ²Houston Methodist Hospital and J.C. Walter Transplant Center, Houston, TX
*Purpose: Compared to Whites, African, Caribbean and Black (ACB) Canadians with kidney failure are less likely to receive a living donor kidney transplant (LDKT), possibly…
2022 American Transplant Congress
Re-Examining the Optimal Threshold for Donor Derived Cell Free DNA in Renal Allograft Rejection
H. Murad¹, M. Merzkani¹, M. Ji¹, S. Chang¹, A. Malone¹, R. Delos Santos¹, T. Alhamad²
¹Washington University in St. Louis, St Louis, MO, ²Washington University in St. Louis, Saint Louis, MO
*Purpose: Due to the invasive nature and potential complications of allograft biopsies, there is an important role for surrogate biomarkers to help identify rejection early,…
2022 American Transplant Congress
Clinical Utility of Donor-Derived Cell-Free DNA During the Period of Recovery of Renal Function After Kidney Transplantation
Y. C. Dreige¹, G. Bittencourt Pereira Lima¹, M. Cristelli¹, M. Nakamura¹, R. D. Foresto¹, P. Pierry¹, R. Ponsirenas², J. Levi¹, J. Medina¹, H. Tedesco¹
¹Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil, ²Medical Affairs, CareDx, Miami, FL
*Purpose: This study evaluates the clinical utility of monitoring donor-derived cell-free DNA (dd-cfDNA), a biomarker of kidney injury, in recipients of high Kidney Donor Profile…